Medinotec Inc. (MDNC): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2025-02-28 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$149.9K

Year ended 2026-02-28

2023-02-28 R&D Expense (USD) 2026-02-28

Period ended	R&D Expense	Change YoY	Source filing
2026-02-28	$149.9K	+64.4%	2026-05-28, From 2025-03-01
2025-02-28	$91.1K	n/c	2026-05-28, From 2024-03-01
2024-02-29	-$22.4K	n/m	2025-05-29, From 2023-03-01
2023-02-28	-$64.9K	n/a	2024-07-05, From 2022-03-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Medinotec Inc. (MDNC)	2026-02-28	$149.9K	+64.4%
WORK Medical Technology Group LTD (WOK)	2025-09-30	$435.3K	+43.9%
Neuroone Medical Technologies Corp (NMTC)	2025-09-30	$4.98M	-1.6%
InspireMD, Inc. (NSPR)	2025-12-31	$15.00M	+10.0%
Nexgel, Inc. (NXGL)	2025-12-31	$2.0K	-97.4%
Beyond Air, Inc. (XAIR)	2026-03-31	$10.24M	-39.2%
INVO Fertility, Inc. (IVF)	2024-12-31	$4.9K	-97.1%
Allurion Technologies, Inc. (ALUR)	2025-12-31	$7.57M	-56.4%
Biotricity Inc. (BTCY)	2026-03-31	$2.76M	+28.2%

Compare MDNC, WOK, NMTC, NSPR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗